Literature DB >> 28699112

Brain Under Stress and Alzheimer's Disease.

Boris Mravec1,2, Lubica Horvathova3, Alexandra Padova4,3.   

Abstract

Modern society is characterized by the ubiquity of stressors that affect every individual to different extents. Furthermore, experimental, clinical, and epidemiological data have shown that chronic activation of the stress response may participate in the development of various somatic as well as neuropsychiatric diseases. Surprisingly, the role that stress plays in the etiopathogenesis of Alzheimer's disease (AD) has not yet been studied in detail and is therefore not well understood. However, accumulated data have shown that neuroendocrine and behavioral changes accompanying the stress response affect neuronal homeostasis and compromise several key neuronal processes. Mediators of the neuroendocrine stress response, if elevated repeatedly or chronically, exert direct detrimental effects on the brain by impairing neuronal metabolism, plasticity, and survival. Stress-induced hormonal and behavioral reactions may also participate in the development of hypertension, atherosclerosis, insulin resistance, and other peripheral disturbances that may indirectly induce neuropathological processes participating in the development and progression of AD. Importantly, stress-induced detrimental effects as etiological factors of AD are attractive because they can be reduced by several approaches including behavioral and pharmacological interventions. These interventions may therefore represent an important strategy for prevention or attenuation of the progression of AD.

Entities:  

Keywords:  Amyloid β; Corticotropin-releasing factor; Glucocorticoids; Glutamate; Locus coeruleus; Neuroinflammation; Norepinephrine; Plasticity; Tau protein

Mesh:

Year:  2017        PMID: 28699112     DOI: 10.1007/s10571-017-0521-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  97 in total

Review 1.  Brain on stress: how the social environment gets under the skin.

Authors:  Bruce S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 2.  Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets.

Authors:  Dénes Zádori; Gábor Veres; Levente Szalárdy; Péter Klivényi; József Toldi; László Vécsei
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo.

Authors:  W J Burke; S W Li; D S Zahm; H Macarthur; L L Kolo; T C Westfall; M Anwar; S B Glickstein; D A Ruggiero
Journal:  Brain Res       Date:  2001-02-09       Impact factor: 3.252

4.  The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand.

Authors:  Lane K Bekar; Helen S Wei; Maiken Nedergaard
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-08       Impact factor: 6.200

Review 5.  Stress mechanisms and metabolic complications.

Authors:  I Kyrou; C Tsigos
Journal:  Horm Metab Res       Date:  2007-06       Impact factor: 2.936

6.  Hypoxia-induced tau phosphorylation and memory deficit in rats.

Authors:  Chang-E Zhang; Xifei Yang; Lingyun Li; Xiaojing Sui; Qing Tian; Wei Wei; Jianzhi Wang; Gongping Liu
Journal:  Neurodegener Dis       Date:  2014-06-27       Impact factor: 2.977

Review 7.  Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity.

Authors:  D Suri; V A Vaidya
Journal:  Neuroscience       Date:  2012-09-09       Impact factor: 3.590

8.  Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

Authors:  L J Launer; K Andersen; M E Dewey; L Letenneur; A Ott; L A Amaducci; C Brayne; J R Copeland; J F Dartigues; P Kragh-Sorensen; A Lobo; J M Martinez-Lage; T Stijnen; A Hofman
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

Review 9.  Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.

Authors:  Chris G Parsons; Albrecht Stöffler; Wojciech Danysz
Journal:  Neuropharmacology       Date:  2007-08-10       Impact factor: 5.250

Review 10.  Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.

Authors:  Steven A Harris; Elizabeth A Harris
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more
  5 in total

Review 1.  The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Biochem Soc Trans       Date:  2018-03-09       Impact factor: 5.407

2.  A Novel Methodology Using Dexamethasone to Induce Neuronal Differentiation in the CNS-Derived Catecholaminergic CAD Cells.

Authors:  Ekkaphot Khongkla; Kwanchanok Uppakara; Nittaya Boonmuen; Kanit Bhukhai; Witchuda Saengsawang
Journal:  Cell Mol Neurobiol       Date:  2021-05-31       Impact factor: 4.231

3.  Chronic stress induces NPD-like behavior in APPPS1 and WT mice with subtle differences in gene expression.

Authors:  Amalie Clement; Mads M Pedersen; Allan Stensballe; Ove Wiborg; Ayodeji A Asuni
Journal:  Genes Brain Behav       Date:  2021-08-23       Impact factor: 3.708

Review 4.  An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.

Authors:  Stephen D Skaper; Laura Facci; Morena Zusso; Pietro Giusti
Journal:  Front Cell Neurosci       Date:  2018-03-21       Impact factor: 5.505

5.  Rab35 and glucocorticoids regulate APP and BACE1 trafficking to modulate Aβ production.

Authors:  Viktoriya Zhuravleva; João Vaz-Silva; Mei Zhu; Patricia Gomes; Joana M Silva; Nuno Sousa; Ioannis Sotiropoulos; Clarissa L Waites
Journal:  Cell Death Dis       Date:  2021-12-08       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.